Genelux Corporation
Advertisement
Genelux Corporation, based in Westlake Village, CA, is a biopharmaceutical company focused on developing innovative therapeutics aimed at redefining immuno-oncology for various cancer indications. Their lead clinical candidate, OlviVec, is a modified form of the oncolytic vaccinia virus, currently being tested in a Phase 3 clinical trial for the treatment of platinum-resistant refractory ovarian cancer.
Utilizing their proprietary CHOICE discovery platform, Genelux has created a versatile pipeline of oncolytic immunotherapy products designed to selectively target and kill tumor cells while sparing normal cells. The company is committed to providing access to investigational therapies for patients with serious or life-threatening conditions who have limited treatment options.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
